发明名称 |
Method and kit for rapid isolation of human Foxp3+ Treg cells |
摘要 |
The present invention relates to methods for isolating human forkhead box P3 (Foxp3+) CD4+ regulatory T cells (herein referred to a Foxp3+ Treg cells) from a sample containing (i) peripheral blood mononuclear cells (PBMCs), (ii) a lymphocyte containing fluid, or (iii) a lymphocyte containing tissue, a kit for isolating human Foxp3+ Treg cells, and the use of anti-CD49d antibody for the isolation of human Foxp3+ Treg cells. |
申请公布号 |
US9213028(B2) |
申请公布日期 |
2015.12.15 |
申请号 |
US201314089179 |
申请日期 |
2013.11.25 |
申请人 |
MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN (MDC) |
发明人 |
Roetzschke Olaf;Falk Kirsten;Kleinewietfeld Markus |
分类号 |
C12N5/071;G01N33/535;G01N33/569;C12N5/0783;A61K35/12 |
主分类号 |
C12N5/071 |
代理机构 |
Licata & Tyrrell P.C. |
代理人 |
Licata & Tyrrell P.C. |
主权项 |
1. A method for isolating human Foxp3+ regulatory T cells by negative selection comprising
(a) treating a sample containing (i) peripheral blood mononuclear cells, (ii) a lymphocyte containing fluid, or (iii) a lymphocyte containing tissue with antibodies, wherein said antibodies consist of an anti-CD49d antibody and an anti-CD127 antibody; and (b) depleting the sample of CD49+ and CD127+ cells via the anti-CD49d antibody and anti-CD127 antibody to obtain an enriched population of label- and antibody-free Foxp3+ regulatory T cells. |
地址 |
Berlin DE |